Wordt geladen...
What Makes Sodium-Glucose Co-Transporter-2 Inhibitors Stand out in Heart Failure?
PURPOSE OF REVIEW: We highlight the unique properties of the sodium-glucose cotransporter-2 (SGLT-2 inhibitors) which may lend favorably to their efficient integration in the background of other heart failure (HF) therapies. We also discuss the unique aspects of SGLT-2 inhibitor dosing, lack of titr...
Bewaard in:
| Gepubliceerd in: | Curr Diab Rep |
|---|---|
| Hoofdauteurs: | , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
Springer US
2020
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7548057/ https://ncbi.nlm.nih.gov/pubmed/33040170 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s11892-020-01347-3 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|